Rohit Aggarwal is a Rheumatology/Immunology physician affiliated with University of Pittsburgh. OpenAlex indexes 340 publications with 13,390 citations (h-index 53); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 5th Ave
Suite 3b Falk Medical Building
Pittsburgh, PA 152133403
Telephone
412-647-6700Registry record last updated 6 Jan 2014.
Clinical trials
- Myositis Interstitial Lung Disease Nintedanib Trial
Sponsor: Rohit Aggarwal, MD
- Predictor of Clinical Response to Acthar in Myositis
Sponsor: University of Pittsburgh
- Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
Sponsor: Rohit Aggarwal, MD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20255 payments$54,670openpaymentsdata.cms.gov ↗
- AstraZeneca UK LimitedProgram year20258 payments$37,053openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year202514 payments$21,923openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
32.4%Folate Analog Metabolic Inhibitor13.9%Methotrexate100%Part D≥52 patientsTNF inhibitor3.9%Humira(Cf) Pen67%Humira(Cf)33%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
24.2%Corticosteroid17.8%Prednisone100%Part D≥69 patientsProton pump inhibitor3.3%Omeprazole67%Pantoprazole Sodium33%Part D<11 patients+ 2 more classes in this area
Nervous system
19.7%Opioid Agonist6.8%Tramadol Hcl100%Part D≥20 patientsGabapentinoids5.6%Gabapentin78%Pregabalin22%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2018–2020 per NIH RePORTER. The latest:
- Myositis Patient Centered Tele-Research (My PACER)
University of Pittsburgh at Pittsburgh
FY2020$200,844R01AR071659 - Myositis Patient Centered Tele-Research (My PACER)
University of Pittsburgh at Pittsburgh
FY2019$201,012R01AR071659 - Myositis Patient Centered Tele-Research (My PACER)
University of Pittsburgh at Pittsburgh
FY2018$213,177R01AR071659
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”